Physician profile
John M Lyons
NPI 1588843171
$4,895.91
in general payments reported to CMS, 2019-2025
40 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $704 · 2020: $411 · 2021: $600 · 2022: $854 · 2023: $1,258 · 2024: $690 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,818 · Travel and Lodging: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,817.70 |
| Travel and Lodging | $509.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,056.84 | 2020-2025 | Gore Synecor Biomaterial |
| Intuitive Surgical, INC. | $942.57 | 2019-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $528.84 | 2019-2023 | Echelon Flex, Certus 140 |
| Kerecis Limited | $301.84 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medtronic, INC. | $229.14 | 2021-2025 | Sonicision, Emprint |
| Conmed Corporation | $222.14 | 2022 | |
| Smith+Nephew, INC. | $204.10 | 2019-2022 | |
| Endogastric Solutions, INC | $130.30 | 2021 | |
| Foundation Medicine, INC. | $101.70 | 2019 | |
| Davol INC. | $99.55 | 2022-2024 | Phasix Mesh |
| Pacira Pharmaceuticals Incorporated | $98.67 | 2020-2025 | Exparel |
| Endo Pharmaceuticals INC. | $90.47 | 2019 | |
| Next Science LLC | $82.50 | 2020 | |
| Sirtex Medical INC | $67.85 | 2023 | Sir-Spheres Microspheres |
| Biom'Up Sa | $60.21 | 2019 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.